Page 13 - 《中国药房》2023年6期
P. 13

判断标准比较[J]. 中国药房,2022,33(9):1131-1135.               clinical tool to improve drug therapy in older adults[J]. J
          [12]  American  Geriatrics  Society  Beers  Criteria   Update  Ex‐  Am Med Dir Assoc,2020,21(3):439.e9-439.e13.
                                               ®
              pert  Panel.  American  Geriatrics  Society  2019  updated   [24]  PAZAN  F,WEISS  C,WEHLING  M,et  al. The  EURO-
              AGS Beers criteria  for potentially inappropriate medica‐  FORTA (fit for the aged) list:international consensus vali‐
                             ®
              tion use in older adults[J]. J Am Geriatr Soc,2019,67(4):  dation  of  a  clinical  tool  for  improved  drug  treatment  in
              674-694.                                            older people[J]. Drugs Aging,2018,35(1):61-71.
          [13]  BEERS M H. Explicit criteria for determining potentially   [25]  PAZAN F,WEHLING M. The fit for the aged (FORTA)
              inappropriate medication use by the elderly: an update[J].   project and its clinical implications[J]. Expert Opin Drug
              Arch Intern Med,1997,157(14):1531-1536.             Metab Toxicol,2020,16(4):275-277.
          [14]  O’MAHONY  D.  STOPP/START  criteria  for  potentially   [26]  肖坚,黄娅敏,刘可可,等. 美国老年医学会2019版潜在
              inappropriate  medications/potential  prescribing  omissions   不适当用药的 Beers 标准解读[J]. 药物流行病学杂志,
              in  older  people:origin  and  progress[J].  Expert  Rev  Clin   2019,28(5):341-350.
              Pharmacol,2020,13(1):15-22.                    [27]  ALSHAMMARI H,AL-SAEED E,AHMED Z,et al. Re‐
          [15]  O’MAHONY  D,O’SULLIVAN  D,BYRNE  S,et  al.        viewing  potentially  inappropriate  medication  in  hospita-
              STOPP/START  criteria  for  potentially  inappropriate  pre-  lized patients over 65 using explicit criteria:a systematic
              scribing in older people:version 2[J]. Age Ageing,2015,  literature review[J]. Drug Healthc Patient Saf,2021,13:
              44(2):213-218.                                      183-210.
          [16]  GALLAGHER  P,RYAN  C,BYRNE  S,et  al.  STOPP   [28]  CURTIN  D,GALLAGHER  P  F,O’MAHONY  D.  Ex‐
              (screening tool of older person’s prescriptions)and START   plicit  criteria  as  clinical  tools  to  minimize  inappropriate
              (screening tool to alert doctors to right treatment): con‐  medication  use  and  its  consequences[J].  Ther Adv  Drug
              sensus validation[J]. Int J Clin Pharmacol Ther,2008,46  Saf,2019,10:2042098619829431.
              (2):72-83.                                     [29]  AWAD A,HANNA  O.  Potentially  inappropriate  medica‐
          [17]  王赛,刘琛,张兰,等. 中国老年人潜在不适当用药判断                        tion use among geriatric patients in primary care setting:a
              标准:2017 年版[J]. 药物不良反应杂志,2018,20(1):                 cross-sectional  study  using  the  Beers,STOPP,FORTA
              2-8.                                                and MAI criteria[J]. PLoS One,2019,14(6):e0218174.
          [18]  KUHN-THIEL A M,WEIß C,WEHLING M,et al. Con‐  [30]  MICHALEK C,WEHLING M,SCHLITZER J,et al. Ef‐
              sensus  validation  of  the  FORTA (fit  for  the  aged)list:a   fects of “fit for the aged” (FORTA) on pharmacotherapy
              clinical tool for increasing the appropriateness of pharma‐  and clinical endpoints:a pilot randomized controlled study
              cotherapy  in  the  elderly[J].  Drugs Aging,2014,31(2):  [J]. Eur J Clin Pharmacol,2014,70(10):1261-1267.
              131-140.                                       [31]  WEHLING M,BURKHARDT H,KUHN-THIEL A,et al.
          [19]  WEHLING M. Drug therapy in the elderly:too much or   VALFORTA:a  randomised  trial  to  validate  the  FORTA
              too little,what to do? A new assessment system:fit for the   (fit for the aged) classification[J]. Age Ageing,2016,45
              aged (FORTA)[J].  Dtsch  Med  Wochenschr,2008,133  (2):262-267.
              (44):2289-2291.                                [32]  WEHLING M,COLLINS R,GIL V M,et al. Appropriate‐
          [20]  PAZAN  F,WEISS  C,WEHLING  M,et  al. The  FORTA   ness of oral anticoagulants for the long-term treatment of
              (fit for the aged) list 2021:fourth version of a validated   atrial  fibrillation  in  older  people:results  of  an  evidence-
              clinical aid for improved pharmacotherapy in older adults  based  review  and  international  consensus  validation  pro‐
              [J]. Drugs Aging,2022,39(3):245-247.                cess (OAC-FORTA 2016)[J]. Drugs Aging,2017,34(7):
          [21]  Medizinische  Fakultät  Mannheim.  FORTA:fit  for  the   499-507.
              aged[EB/OL]. [2022-11-16]. https://www.umm.uni-he-  [33]  OELKE M,BECHER K,CASTRO-DIAZ D,et al. Appro‐
              idelberg.de/experimentelle-pharmakologie/research/group-  priateness of oral drugs for long-term treatment of lower
              wehling/.                                           urinary tract symptoms in older persons:results of a sys‐
          [22]  PAZAN  F,GERCKE  Y,WEISS  C,et  al.  The  Japan-  tematic literature review and international consensus vali‐
              FORTA (fit  for  the  aged)  list:consensus  validation  of  a   dation  process (LUTS-FORTA  2014)[J].  Age  Ageing,
              clinical  tool  to  improve  drug  therapy  in  older  adults[J].   2015,44(5):745-755.
              Arch Gerontol Geriatr,2020,91:104217.                         (收稿日期:2022-11-24  修回日期:2023-02-16)
          [23]  PAZAN  F,GERCKE  Y,WEISS  C,et  al.  The  U. S. -                                 (编辑:孙 冰)
              FORTA (fit  for  the  aged)  list:consensus  validation  of  a







          中国药房  2023年第34卷第6期                                                 China Pharmacy  2023 Vol. 34  No. 6    · 647 ·
   8   9   10   11   12   13   14   15   16   17   18